Johnson & Johnson Reports Strong Q1 2026 Earnings with Operational Sales Growth and Guidance Increase

Johnson & Johnson reported 6.4% operational sales growth in Q1 2026, driven by strong performance in Innovative Medicine and MedTech segments. The company raised its full-year 2026 operational sales guidance to $100.2 billion, marking the first time it has reached the $100 billion milestone. Key drivers include successful product launches and strategic acquisitions.

By Moby Intelligence Tue, April 14, 2026 at 7:46 PM GMT+3 3 min read · Yahoo Finance · April 14, 2026, 16:46 UTC

Tickers: $JNJ

Topics: Earnings Financial Performance M&A Integration Operational Growth Product Launch Stock Guidance

Read the full article at Yahoo Finance

More World news

UBS Upgrades Rivian to Buy Rating Amid R2 Potential Motley Fool · November 12, 2026, 16:45 UTC
Stifel Downgrades EVgo to Hold Amid Weakening Growth Outlook Seeking Alpha · November 12, 2026, 16:41 UTC
Rowan Digital Infrastructure Secures Over $1.5 Billion in New Financing Seeking Alpha · November 12, 2026, 16:42 UTC
CAE Reports Q2 2027 Results with Increased EPS Guidance and Strong Defense Growth Motley Fool · November 12, 2026, 16:39 UTC
Alvotech Reports Q3 2026 Financial Results Amid Manufacturing Recovery Motley Fool · November 12, 2026, 16:39 UTC
Jacobs Solutions Declares Quarterly Dividend of $0.36 Per Share Seeking Alpha · November 12, 2026, 16:39 UTC
SOLV Energy Raises Revenue Guidance Following Record Q3 Project Execution Seeking Alpha · November 12, 2026, 16:40 UTC
LiveWorld Reports Q3 Revenue of $2.98 Million and GAAP EPS of -$0.01 Seeking Alpha · November 12, 2026, 16:37 UTC
Jensen Huang Resigns as Nvidia CEO Amid Allegations of Chinese Espionage The Verge · November 12, 2026, 16:30 UTC
Rising New Vehicle Monthly Payments Pose Affordability Risks for Ford and General Motors Motley Fool · November 12, 2026, 16:33 UTC